Furthermore, glioma cells with MCT4/CD147 knockout result more receptive to the treatment with phenformin, a mitochondrial complex I inhibitor, apparently because the tumor cells that survive MCT blockade enter into an “ATP crisis” and die, implying that the use of MCT inhibitors could be a potential therapeutic perspective [243]. This evidence concerns the gene SLC16A1 and glioma.